Dr. Farid Menaa (Bsc. Bioengineering ; Bsc. Physiology ; Msc. Genetics ; National Master Gerontology; Doctor ès Sciences (Paris, France, 2003) ; PhD Biomedicine and Pharmaceutical Sciences (Liège, Belgium, 2016); three international post-doctoral trainings in Oncology, Dermatology, and Hematology ; MBA Business Development & Management and MD candidate), is an experienced and skilled inter- and multi-disciplinary professional. Dr. Menaa earned his degrees with high distinctions from prestigious universities and institutions worldwide. During his career, Dr. Menaa followed complementary formations in Marine Biology (France), Biochemistry/Chemistry/Biophysics (USA), Stem Cells (Germany), Genomics (France, Brazil), Pharmacy (Belgium). Dr. Menaa has over than 15 years experiences in academic institutions and more than 10 years in (bio)pharmaceutical industries such as Guerbet SA, SANOFI, Fluorotronics, Inc. Polyglot, he is experienced as Professor, Principal Investigator, Executive Director, Healthcare, Consulting for companies such as Exiquon and Novartis, Supervisor/Group leader, Thesis Evaluator, Advisor, Editor, Editor-in-Chief, Reviewer, Event organizer, Speaker, Chairman, Moderator, Scientific collaborator, Entrepreneur, Member of various medical and scientific associations. In 2009, Dr. Menaa was promoted to Chief Scientific Officer and R&D&I Executive Vice-President for Fluorotronics, Inc, CA, USA, a leading company in Fluorine Chemistry. He co-developed and applied an innovative green technology called “SpectroFluor™” to Nanomedicine, Oncology, Pharmaceutical and Life Sciences. In 2013, he successfully organized the “Target Meeting´s 1st World Nanomedicine and Nanobiotechnology Online Conference” (http://www.targetmeeting.com; 2013). Dr. Menaa is currently Chief Editor of J. Nanomed Nanotech (http://www.omicsonline.org/editorialboard-nanomedicine-nanotechnology-open-access.php), an independent Scientist, and an International Consulting Healthcare Expert. Dr. Menaa has (co-)authored more than 100 scientific articles including 1 book, and participated to over 200 scientific events. Eventually, the Dr. Menaa’s holitic concept led him to contribute for various international clinical and R&D&I projects in order to prevent, implement early diagnosis, and develop efficient and safer therapeutic options, with the main goal to improve patients’ life quality.
Farid Menaa research interestincludes polyphenols; nutraceuticals; cosmeceuticals; fatty acids; phytomedicine; toxicology; pharmacology; nanotechnology.